source
- FDA delays review of Novo's hemophilia A drug denecimig over factory issuesUS regulators have extended the review of Novo's hemophilia A injection, denecimig, because of problems at an unnamed manufacturing facility. The FDA said ongoing remediation activities observed d…
- Genentech parts ways with global AI head Richard BonneauGenentech, the Roche biotech unit, announced that its global head of artificial intelligence for drug discovery, computational biologist Richard Bonneau, has left the company effective immediately.…